Effectiveness of Immersive Virtual Reality on Biomarkers and Clinical and Clinimetric Variables in Patients with Persistent Shoulder Pain

NANot yet recruitingINTERVENTIONAL
Enrollment

42

Participants

Timeline

Start Date

March 1, 2025

Primary Completion Date

December 20, 2025

Study Completion Date

February 1, 2026

Conditions
Shoulder Pain
Interventions
DEVICE

Immersive Virtual Reality

"Participants in the experimental group will follow a treatment program that combines standard care with an immersive virtual reality (IVR) intervention. During the first 4 weeks, participants will undergo the IVR intervention, followed by the same standard treatment as the control group for the subsequent 8 weeks.~IVR Intervention Protocol:~Sessions and Equipment: Participants will attend up to 12 IVR sessions using a head-mounted device (HMD), the Meta Quest III, equipped with a hand-tracking system (Meta VR, Facebook, California) to enable interaction with the therapeutic software Dynamics PainRehab (Dynamics VR Rehab, Seville, Spain). The Meta Quest III HMD is chosen for its commercial availability, widespread use, minimal visual latency, and user-friendly interface. The software application, Hombro PainRehab, features multisensory inputs (vision and sound), high-quality graphics, head and hand tracking, and provides a highly immersive experience. The IVR intervention incorporate"

PROCEDURE

Exercise

Participants assigned to the control group will receive standard treatment for rotator cuff-related shoulder pain. This will consist of standardized therapeutic exercise performed for 25 minutes, 3 times per week, over a 12-week period. The exercise regimen will be individualized based on intensity, utilizing the Rate of Perceived Exertion (RPE) scale, with the goal of achieving intensity levels of 6-8 on a scale of 0 to 10.

Trial Locations (1)

28223

Universidad Francisco de Vitoria, Madrid

All Listed Sponsors
lead

Universidad Francisco de Vitoria

OTHER

NCT06795464 - Effectiveness of Immersive Virtual Reality on Biomarkers and Clinical and Clinimetric Variables in Patients with Persistent Shoulder Pain | Biotech Hunter | Biotech Hunter